Received Nov 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
first dose of Havrix back in January 2023 and now wants to receive the second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (First dose rceived in JAN-2023). The patient did not receive the 2nd dose of Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incomplete course of vaccination (Verbatim: first dose of Havrix back in January 2023 and now wants to receive the second dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-Nov-2025 Pharmacist wanted to know how to proceed with a patient that received the first dose of Havrix back in January 2023 and now wants to receive the second dose.